PF-00489791 For The Treatment Of Raynaud's

NCT01090492 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Raynaud's Disease
Peripheral Vascular Disease

Interventions

DRUG: PF-00489791
DRUG: PF-00489791
DRUG: PF-00489791
DRUG: PF-00489791
DRUG: PF-00489791
DRUG: PF-00489791
DRUG: PF-00489791
DRUG: PF-00489791

Sponsor

Pfizer